Jan 8, 2026
GSK licenses Noetik’s OCTO Virtual Cell Foundation Models in $50M Partnership to Advance Cancer R&D
Jun 3, 2025
Linearis receives a contribution from the Government of Canada to support the $7M modernization of its metabolomics platform, integrating artificial intelligence
May 7, 2025
Zilia Closes Bridge Round with Participation from Existing and New Investors Including Linearis Ventures
Mar 27, 2025
Linearis Launches High-Throughput Metabolomics Platform to Drive AI Integration and Life Sciences Investment
Mar 10, 2025
Linearis Unveils Its Investments and Inaugurates Its New Metabolomics Laboratory
Linearis Welcomes John Reichenbach as a New Advisor
Feb 18, 2025
Feldan Therapeutics Accelerates Growth With Strategic Investment From Linearis Ventures
Nov 12, 2024
Linearis is Pioneering Large Scale Metabolomic Analysis: A Pan-Canadian Collaboration and New Frontier in Cancer Precision Medicine
Aug 29, 2024
Linearis Ventures and Other Funds Invest in Noetik’s Oversubscribed Series A $40M USD Accelerating AI-Drug Development Platform for Precision Cancer Therapies
May 8, 2024
Linearis Partners with Mila in a Vast Biomanufacturing Funding Initiative
Feb 8, 2024
Quebec City invests $3M in Linearis Ventures, a venture capital fund combining life science and artificial intelligence.
Nov 28, 2023
Linearis Opens its New Laboratory Offering an AI Biomarkers Analytical Platform for Innovation Against Cancer, Diabetes, Antimicrobial Resistance, and Other Metabolic Diseases
